1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Jung, H.J.
Lee, C.W.
Earm, Y.E.
Kim, J.I.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
H2 N
16.023
AMINO GROUP
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
To be Published
0353
Solution structure of GsMTx-4, a peptide blocker of cation-selective stretch-activated channels
10.2210/pdb1lu8/pdb
pdb_00001lu8
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
4107.934
venom toxin peptide MTx4
residues 1-34
1
syn
polymer
GsMTx-4
no
yes
GCLEFWWKCNPNDDKCCRPKLKCSKLFKLCNFSF(NH2)
GCLEFWWKCNPNDDKCCRPKLKCSKLFKLCNFSFX
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conn
struct_site
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2004-01-27
1
1
2008-04-28
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_conn.pdbx_leaving_atom_flag
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
RCSB
Y
PDBJ
2002-05-22
REL
REL
This peptide was synthesized chemically.
sample
Additional comments about the NMR refinement can be placed here, e.g.The structures are based on a total of 630 restraints, 591 are NOE-derived distance constraints, 27 dihedral angle restraints, 12 distance restraints from hydrogen bonds, and 9 distance restraints from disulfide bonds.
This structure was determined using standard 2D homonuclear techniques.
The submitted confomer models are those with the lowest energy, the least restraint violations
100
20
2D NOESY
DQF-COSY
PE-COSY
0
3.5
ambient
288
K
distance geometry simulated annealing
3
closest to the average
10mM GsMTx-4
90% H2O/10% D2O
A. T. Brunger
structure solution
X-PLOR
3.851
refinement
X-PLOR
3.851
Bruker
collection
XwinNMR
3.0
Bruker
processing
XwinNMR
3.0
600
Bruker
DRX
500
Bruker
DMX
GLY
1
n
1
GLY
1
A
CYS
2
n
2
CYS
2
A
LEU
3
n
3
LEU
3
A
GLU
4
n
4
GLU
4
A
PHE
5
n
5
PHE
5
A
TRP
6
n
6
TRP
6
A
TRP
7
n
7
TRP
7
A
LYS
8
n
8
LYS
8
A
CYS
9
n
9
CYS
9
A
ASN
10
n
10
ASN
10
A
PRO
11
n
11
PRO
11
A
ASN
12
n
12
ASN
12
A
ASP
13
n
13
ASP
13
A
ASP
14
n
14
ASP
14
A
LYS
15
n
15
LYS
15
A
CYS
16
n
16
CYS
16
A
CYS
17
n
17
CYS
17
A
ARG
18
n
18
ARG
18
A
PRO
19
n
19
PRO
19
A
LYS
20
n
20
LYS
20
A
LEU
21
n
21
LEU
21
A
LYS
22
n
22
LYS
22
A
CYS
23
n
23
CYS
23
A
SER
24
n
24
SER
24
A
LYS
25
n
25
LYS
25
A
LEU
26
n
26
LEU
26
A
PHE
27
n
27
PHE
27
A
LYS
28
n
28
LYS
28
A
LEU
29
n
29
LEU
29
A
CYS
30
n
30
CYS
30
A
ASN
31
n
31
ASN
31
A
PHE
32
n
32
PHE
32
A
SER
33
n
33
SER
33
A
PHE
34
n
34
PHE
34
A
NH2
35
n
35
NH2
35
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
LYS
22
A
N
LYS
22
A
O
ASN
31
A
O
ASN
31
6
A
A
H
O
SER
LEU
24
29
1.53
8
A
A
H
O
SER
LEU
24
29
1.54
11
A
A
H
O
SER
LEU
24
29
1.57
12
A
A
H
O
SER
LEU
24
29
1.50
13
A
A
HB3
HN1
PHE
NH2
34
35
1.35
13
A
A
H
O
SER
LEU
24
29
1.57
15
A
A
O
H
ASN
ASN
10
12
1.56
16
A
A
H
O
SER
LEU
24
29
1.47
17
A
A
H
O
SER
LEU
24
29
1.60
18
A
A
H
O
SER
LEU
24
29
1.58
19
A
A
H
O
SER
LEU
24
29
1.57
20
A
A
O
H
ASN
ASN
10
12
1.58
1
A
ARG
18
0.316
SIDE CHAIN
2
A
ARG
18
0.274
SIDE CHAIN
3
A
ARG
18
0.078
SIDE CHAIN
4
A
ARG
18
0.207
SIDE CHAIN
5
A
ARG
18
0.277
SIDE CHAIN
6
A
ARG
18
0.276
SIDE CHAIN
7
A
ARG
18
0.274
SIDE CHAIN
8
A
ARG
18
0.307
SIDE CHAIN
9
A
ARG
18
0.261
SIDE CHAIN
10
A
ARG
18
0.318
SIDE CHAIN
11
A
ARG
18
0.316
SIDE CHAIN
12
A
ARG
18
0.266
SIDE CHAIN
13
A
ARG
18
0.178
SIDE CHAIN
14
A
ARG
18
0.264
SIDE CHAIN
15
A
ARG
18
0.266
SIDE CHAIN
16
A
ARG
18
0.275
SIDE CHAIN
17
A
ARG
18
0.273
SIDE CHAIN
18
A
ARG
18
0.296
SIDE CHAIN
19
A
ARG
18
0.278
SIDE CHAIN
20
A
ARG
18
0.256
SIDE CHAIN
1
A
LEU
3
-85.66
-149.95
1
A
TRP
6
-161.23
43.55
1
A
LYS
8
-45.83
157.14
1
A
ASP
13
179.33
55.68
1
A
LYS
15
-153.71
13.62
1
A
LYS
20
173.99
43.24
1
A
CYS
23
-43.15
152.72
1
A
PHE
27
-144.92
10.09
1
A
PHE
32
179.28
-79.75
2
A
CYS
2
-79.86
-169.03
2
A
LEU
3
-97.03
-138.86
2
A
GLU
4
-116.53
-164.75
2
A
TRP
6
-161.01
60.08
2
A
LYS
8
-43.10
158.65
2
A
ASP
13
-162.32
52.97
2
A
CYS
17
-43.80
163.16
2
A
LYS
20
174.71
35.93
2
A
CYS
23
-36.82
148.83
2
A
PHE
27
-147.79
15.78
2
A
ASN
31
-112.00
-141.58
2
A
PHE
32
-79.44
-164.24
2
A
SER
33
-110.11
-76.05
3
A
CYS
2
-53.67
-170.36
3
A
LEU
3
-88.18
-134.92
3
A
GLU
4
-119.33
-164.43
3
A
TRP
6
-161.11
49.64
3
A
LYS
8
-39.30
152.35
3
A
ASP
13
-148.32
49.41
3
A
ASP
14
-48.41
151.54
3
A
CYS
17
-46.06
152.91
3
A
LYS
20
175.66
32.68
3
A
CYS
23
-37.96
146.98
3
A
ASN
31
-112.18
-149.26
3
A
SER
33
-117.41
50.46
4
A
CYS
2
-53.28
-169.84
4
A
LEU
3
-94.18
-135.35
4
A
TRP
6
-160.42
55.93
4
A
LYS
8
-45.16
157.62
4
A
ASP
13
-162.15
62.57
4
A
CYS
16
-42.73
151.29
4
A
CYS
17
-45.90
169.88
4
A
PRO
19
-79.68
49.23
4
A
LYS
20
80.96
32.36
4
A
CYS
23
-38.33
148.35
4
A
ASN
31
-111.80
-143.48
4
A
PHE
32
-67.11
-164.25
5
A
CYS
2
-54.73
-168.88
5
A
GLU
4
-71.02
-165.82
5
A
TRP
6
-161.15
55.50
5
A
LYS
8
-45.48
153.23
5
A
ASP
13
-174.69
53.47
5
A
CYS
16
-44.80
154.34
5
A
LYS
20
-180.00
38.91
5
A
ASN
31
-116.65
-150.09
6
A
CYS
2
-57.46
-169.73
6
A
LEU
3
-101.16
-152.97
6
A
TRP
6
-160.86
47.46
6
A
LYS
8
-41.75
159.09
6
A
ASP
13
-142.17
54.69
6
A
CYS
17
-44.67
166.17
6
A
LYS
20
168.53
34.56
6
A
ASN
31
-114.03
-149.42
7
A
TRP
6
-160.88
55.91
7
A
LYS
8
-44.33
160.52
7
A
ASP
13
-178.17
50.85
7
A
ASP
14
-43.02
159.60
7
A
LYS
15
-148.43
-33.47
7
A
CYS
17
-52.38
-174.85
7
A
ASN
31
-105.95
-140.51
8
A
LEU
3
-88.08
-153.69
8
A
GLU
4
-103.42
-163.85
8
A
TRP
6
-162.52
43.90
8
A
LYS
8
-36.31
151.59
8
A
ASP
13
-151.43
47.02
8
A
CYS
17
-42.26
151.47
8
A
LYS
20
172.56
36.72
8
A
ASN
31
-122.81
-147.67
8
A
PHE
32
-64.42
-172.15
8
A
SER
33
-112.47
-88.97
9
A
CYS
2
33.08
-160.45
9
A
LEU
3
-109.64
-141.21
9
A
GLU
4
-117.73
-163.27
9
A
TRP
6
-161.06
52.76
9
A
LYS
8
-41.79
157.65
9
A
ASP
13
-142.10
50.95
9
A
LYS
20
165.07
43.70
9
A
CYS
23
-35.44
149.17
9
A
LYS
28
83.80
32.20
9
A
ASN
31
-113.53
-141.81
10
A
CYS
2
-61.06
-169.64
10
A
LEU
3
-89.12
-102.44
10
A
GLU
4
-163.56
-161.18
10
A
TRP
6
-160.94
56.29
10
A
LYS
8
-41.20
155.47
10
A
PRO
11
-67.45
51.96
10
A
ASN
12
-161.32
-42.27
10
A
ASP
13
-147.63
48.53
10
A
CYS
17
-50.85
-178.07
10
A
CYS
23
-40.33
150.21
10
A
PHE
27
-150.83
15.44
10
A
PHE
32
166.08
-75.36
11
A
CYS
2
-54.64
-167.72
11
A
LEU
3
-100.43
-157.11
11
A
TRP
6
-160.85
53.02
11
A
LYS
8
-46.02
157.77
11
A
ASP
13
-144.33
51.73
11
A
CYS
16
-43.74
152.01
11
A
CYS
17
-45.99
154.01
11
A
LYS
20
178.65
41.38
11
A
ASN
31
-112.99
-133.81
11
A
SER
33
-67.00
-152.54
12
A
CYS
2
-125.62
-168.69
12
A
LEU
3
-84.09
-124.02
12
A
GLU
4
-139.03
-157.78
12
A
TRP
6
-160.72
47.51
12
A
LYS
8
-40.45
156.47
12
A
CYS
17
-45.09
153.32
12
A
LYS
20
178.84
46.53
12
A
CYS
23
-39.06
140.02
12
A
LYS
28
82.66
21.70
12
A
PHE
32
-175.70
-70.36
13
A
GLU
4
-63.55
-169.04
13
A
TRP
6
-161.61
49.81
13
A
ASP
13
-170.13
54.17
13
A
CYS
17
-45.04
159.95
13
A
LYS
20
175.32
32.17
13
A
CYS
23
-39.19
147.58
13
A
PHE
32
177.45
-68.06
13
A
SER
33
-60.61
-159.74
14
A
CYS
2
-54.63
-171.74
14
A
LEU
3
-95.48
-152.06
14
A
TRP
6
-160.45
54.80
14
A
LYS
8
-41.16
156.71
14
A
ASP
13
-147.61
52.90
14
A
ASP
14
-40.00
114.83
14
A
CYS
17
-44.34
162.28
14
A
LYS
20
168.32
46.57
14
A
CYS
23
-44.61
156.26
14
A
PHE
27
-140.17
10.43
14
A
ASN
31
-100.13
-152.45
14
A
SER
33
-141.83
-80.75
15
A
CYS
2
-49.05
-178.60
15
A
LEU
3
-78.10
-163.41
15
A
TRP
6
-161.17
54.45
15
A
LYS
8
-39.11
150.44
15
A
PRO
11
-65.04
58.99
15
A
ASN
12
-159.78
-40.90
15
A
ASP
13
-153.74
45.79
15
A
CYS
17
-39.97
154.77
15
A
LYS
20
170.93
38.20
15
A
ASN
31
-118.81
-152.79
15
A
SER
33
175.30
118.64
16
A
GLU
4
-75.40
-168.30
16
A
TRP
6
-162.43
42.32
16
A
LYS
8
-35.64
136.65
16
A
CYS
17
-46.31
164.82
16
A
LYS
20
170.56
53.43
16
A
PHE
32
179.19
-72.46
16
A
SER
33
-172.04
-164.79
17
A
CYS
2
-65.89
-165.72
17
A
LEU
3
-104.83
-139.76
17
A
GLU
4
-113.50
-164.99
17
A
TRP
6
-162.22
52.84
17
A
ASP
14
-39.42
148.37
17
A
LYS
15
-146.53
-30.41
17
A
CYS
16
-41.88
151.45
17
A
CYS
17
-51.47
179.56
17
A
LYS
20
72.07
41.99
17
A
LEU
26
-41.70
-82.79
17
A
LYS
28
72.69
35.65
17
A
ASN
31
-105.95
-138.55
18
A
CYS
2
-55.77
-166.91
18
A
LEU
3
-95.39
-148.58
18
A
PHE
5
-59.76
-9.21
18
A
TRP
6
-152.71
59.59
18
A
LYS
8
-43.69
153.11
18
A
ASP
13
-168.22
52.77
18
A
CYS
17
-45.63
166.70
18
A
LYS
20
75.32
56.71
18
A
PHE
27
-142.90
14.12
18
A
ASN
31
-134.82
-138.69
18
A
PHE
32
-76.98
-160.86
18
A
SER
33
-142.53
-37.40
19
A
CYS
2
-58.06
-170.29
19
A
LEU
3
-100.22
-157.43
19
A
TRP
6
-161.00
53.14
19
A
LYS
8
-39.96
154.57
19
A
ASP
13
-167.01
53.89
19
A
CYS
17
-42.73
163.97
19
A
LYS
20
164.59
37.90
19
A
CYS
23
-39.88
144.46
19
A
ASN
31
-114.53
-145.14
20
A
GLU
4
-55.01
-167.52
20
A
TRP
6
-162.19
56.01
20
A
LYS
8
-45.92
153.57
20
A
CYS
9
-161.64
-169.40
20
A
PRO
11
-66.79
55.69
20
A
ASN
12
-161.13
-39.91
20
A
ASP
13
-154.31
47.68
20
A
CYS
17
-41.35
152.53
20
A
LYS
20
172.33
34.08
20
A
CYS
23
-42.37
156.75
20
A
ASN
31
-114.30
-152.59
Solution structure of GsMTx-4
1
N
N
disulf
2.020
A
CYS
2
A
SG
CYS
2
1_555
A
CYS
17
A
SG
CYS
17
1_555
disulf
2.020
A
CYS
9
A
SG
CYS
9
1_555
A
CYS
23
A
SG
CYS
23
1_555
disulf
2.020
A
CYS
16
A
SG
CYS
16
1_555
A
CYS
30
A
SG
CYS
30
1_555
covale
1.380
both
A
PHE
34
A
C
PHE
34
1_555
A
NH2
35
A
N
NH2
35
1_555
TOXIN
Triple stranded antiparellel beta-sheet, inhibitory cystine knot, TOXIN
AAP79435
GB
1
47
32309340
GCLEFWWKCNPNDDKCCRPKLKCSKLFKLCNFSF
47
80
1LU8
1
34
32309340
A
1
1
34
2
anti-parallel
A
LEU
21
A
LEU
21
A
SER
24
A
SER
24
A
LEU
29
A
LEU
29
A
PHE
32
A
PHE
32
BINDING SITE FOR RESIDUE NH2 A 35
A
NH2
35
Software
2
A
LEU
21
A
LEU
21
2
1_555
A
PHE
34
A
PHE
34
2
1_555